140 related articles for article (PubMed ID: 24440747)
1. Hic-5 influences genomic and non-genomic actions of the androgen receptor in prostate myofibroblasts.
Leach DA; Need EF; Trotta AP; Grubisha MJ; DeFranco DB; Buchanan G
Mol Cell Endocrinol; 2014 Mar; 384(1-2):185-99. PubMed ID: 24440747
[TBL] [Abstract][Full Text] [Related]
2. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
[TBL] [Abstract][Full Text] [Related]
3. Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.
Heitzer MD; DeFranco DB
Cancer Res; 2006 Jul; 66(14):7326-33. PubMed ID: 16849583
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5.
Maudsley S; Davidson L; Pawson AJ; Freestone SH; López de Maturana R; Thomson AA; Millar RP
Neuroendocrinology; 2006; 84(5):285-300. PubMed ID: 17202804
[TBL] [Abstract][Full Text] [Related]
5. Hic-5/ARA55: a prostate stroma-specific AR coactivator.
Heitzer MD; DeFranco DB
Steroids; 2007 Feb; 72(2):218-20. PubMed ID: 17166536
[TBL] [Abstract][Full Text] [Related]
6. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
[TBL] [Abstract][Full Text] [Related]
7. Aging up-regulates ARA55 in stromal cells, inducing androgen-mediated prostate cancer cell proliferation and migration.
Zou Q; Cui D; Liang S; Xia S; Jing Y; Han B
J Mol Histol; 2016 Jun; 47(3):305-15. PubMed ID: 27178620
[TBL] [Abstract][Full Text] [Related]
8. Hic-5 Mediates TGFβ-Induced Adhesion in Vascular Smooth Muscle Cells by a Nox4-Dependent Mechanism.
Fernandez I; Martin-Garrido A; Zhou DW; Clempus RE; Seidel-Rogol B; Valdivia A; Lassègue B; García AJ; Griendling KK; San Martin A
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1198-206. PubMed ID: 25814672
[TBL] [Abstract][Full Text] [Related]
9. Matrix mechanics controls FHL2 movement to the nucleus to activate p21 expression.
Nakazawa N; Sathe AR; Shivashankar GV; Sheetz MP
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6813-E6822. PubMed ID: 27742790
[TBL] [Abstract][Full Text] [Related]
10. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
[TBL] [Abstract][Full Text] [Related]
11. Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.
Li X; Martinez-Ferrer M; Botta V; Uwamariya C; Banerjee J; Bhowmick NA
Oncogene; 2011 Jan; 30(2):167-77. PubMed ID: 20818421
[TBL] [Abstract][Full Text] [Related]
12. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
Simanainen U; McNamara K; Gao YR; Handelsman DJ
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
[TBL] [Abstract][Full Text] [Related]
13. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
[TBL] [Abstract][Full Text] [Related]
14. The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling.
Omoto T; Kim-Kaneyama JR; Lei XF; Orimo A; Ohnishi K; Yoshihara K; Miyauchi A; Li S; Gao L; Umemoto T; Tanaka J; Nakahara K; Takeya M; Ishida F; Kudo SE; Haraguchi S; Miyazaki T; Miyazaki A
Oncogene; 2018 Mar; 37(9):1205-1219. PubMed ID: 29242607
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate.
Bryant KG; Camacho J; Jasmin JF; Wang C; Addya S; Casimiro MC; Fortina P; Balasubramaniam S; Knudsen KE; Schwarting R; Lisanti MP; Mercier I
Int J Biochem Cell Biol; 2011 Sep; 43(9):1318-29. PubMed ID: 21601007
[TBL] [Abstract][Full Text] [Related]
16. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1.
Gerdes MJ; Larsen M; Dang TD; Ressler SJ; Tuxhorn JA; Rowley DR
Prostate; 2004 Feb; 58(3):299-307. PubMed ID: 14743470
[TBL] [Abstract][Full Text] [Related]
17. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
19. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
Vis AN; Schröder FH
BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
[TBL] [Abstract][Full Text] [Related]
20. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells.
Gross M; Liu B; Tan J; French FS; Carey M; Shuai K
Oncogene; 2001 Jun; 20(29):3880-7. PubMed ID: 11439351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
